Abstract

Vitamin D is an essential micronutrient whose demand is heightened during pregnancy to support the growth of the fetus. Furthermore, the fetus does not produce vitamin D and hence relies exclusively on the supply of maternal vitamin D through the placenta. Vitamin D inadequacy is linked with pregnancy complications and adverse infant outcomes. Hence, early predictive markers of vitamin D inadequacy such as genetic vulnerability are important to both mother and offspring. In this multi-ethnic Asian birth cohort study, we report the first genome-wide association analysis (GWAS) of maternal and fetal vitamin D in circulation. For this, 25-hydroxyvitamin D (25OHD) was measured in the antenatal blood of mothers during mid gestation (n=942), and the cord blood of their offspring at birth (n=812). Around ~7 million single nucleotide polymorphisms (SNPs) were regressed against 25OHD concentrations to identify genetic risk variants. About 41% of mothers had inadequate 25OHD (≤75nmol/L) during pregnancy. Antenatal 25OHD was associated with ethnicity [Malay (Β=−22.32nmol/L, p=2.3×10−26); Indian (Β=−21.85, p=3.1×10−21); reference Chinese], age (Β=0.47/year, p=0.0058), and supplement intake (Β=16.47, p=2.4×10−13). Cord blood 25OHD highly correlated with antenatal vitamin D (r=0.75) and was associated with ethnicity [Malay (Β=−4.44, p=2.2×10−7); Indian (Β=−1.99, p=0.038); reference Chinese]. GWAS analysis identified rs4588, a missense variant in the group-specific component (GC) gene encoding vitamin D binding protein (VDBP), and its defining haplotype, as a risk factor for low antenatal (Β=−8.56/T-allele, p=1.0×10−9) and cord blood vitamin D (Β=−3.22/T-allele, p=1.0×10−8) in all three ethnicities. We also discovered a novel association in a SNP downstream of CYP2J2 (rs10789082), a gene involved in 25-hydroxylation of vitamin D, with vitamin D in pregnant women (Β=−7.68/G-allele, p=1.5×10−8), but not their offspring. As the prevention and early detection of suboptimal vitamin D levels are of profound importance to both mother and offspring’s health, the genetic risk variants identified in this study allow risk assessment and precision in early intervention of vitamin D deficiency.

Highlights

  • Vitamin D is a steroid hormone that plays an important role in calcium homeostasis and metabolic pathways, and is linked with multiple human health outcomes (Theodoratou et al, 2014)

  • We discovered a novel association in a single nucleotide polymorphisms (SNPs) downstream of CYP2J2, a gene involved in 25-hydroxylation of vitamin D, with vitamin D in pregnant women (Β = −7.68/Gallele, p = 1.5 × 10−8), but not their offspring

  • We investigate the epidemiological and genetic risk factors associated with antenatal and cord blood vitamin D concentrations

Read more

Summary

Introduction

Vitamin D is a steroid hormone that plays an important role in calcium homeostasis and metabolic pathways, and is linked with multiple human health outcomes (Theodoratou et al, 2014). The most abundant form of vitamin D is vitamin D3 (cholecalciferol), which is synthesized in the skin by exposure of 7-dehydrocholesterol to UV B radiation from sun. After synthesis in the skin or consumption through diet, vitamin D circulates in the bloodstream and is rapidly converted to 25-hydroxycholecalciferol (25OHD) by cytochrome P450 (CYP) enzyme in the liver. Subsequent 1-hydroxylation in the kidney converts 25-hydroxycholecalciferol to the active metabolite 1,25-dihydroxycholecalciferol [1,25(OH)2D]. Vitamin D binding protein (VDBP) is the principal transporter of vitamin D and its metabolites in the blood stream and helps mobilize them to their target tissues. Many tissues express the vitamin D receptor (VDR), which binds to 1,25(OH)2D and heterodimerises with the retinoic X receptor (RXR) to form a transcription factor. Since RXR is involved in cell proliferation, differentiation, and organogenesis, it plays a critical role in pregnancy and fetal development (Szanto et al, 2004)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call